With 20 abstracts accepted, Parexel’s experts present posters with a range of research and outcomes that impact innovation, value and healthcare decision-making.
View Parexel’s posters below, including those we’ve co-authored with clients. Please connect with our authors to find out more, or visit us at the event at booth #1007.
ISPOR 2024 posters
Landscaping for product positioning
Understanding the Humanistic and Economic Burden Associated with Early-Stage Hr+/HER2- Breast Cancer: A Systematic Literature Review
Poster session 1: Monday, May 6th from 10:30 am – 1:30 pm
The Economics Promises of a Cure – Best Practices to Guide Economic Negotiations for the Reimbursement of Curative Therapies for Cancer
Poster session 3: Tuesday, May 7th from 10:30 am – 1:30 pm
Cost-Effectiveness Analysis of Nivolumab Plus Relatlimab (NIVO+RELA) Versus Current Standard of Care (SOC) for Patients with Unresectable or Metastatic Melanoma in Canada
Poster session 4: Tuesday, May 7th from 3:30 pm – 6:30 pm
Theoretical Exploration of the Inclusion of Non-Traditional Multiple Sclerosis Measurement Variables on the Cost-Effectiveness of Future Treatments
Poster session 5: Wednesday, May 8th from 9:00 am – 11:30 am
Novel data and modeling approaches to value demonstration
Assessing the impact of the prior distribution for the within-study correlation in bivariate network meta-analysis: a case study in relapsed/refractory multiple myeloma
Poster session 3: Tuesday, May 7th from 10:30 am – 1:30 pm
Modeling the patient-level dependence of overall survival on time to objective response in oncology studies using copulas
Poster session 4: Tuesday, May 7th from 3:30 pm – 6:30 pm
Incorporating cure effect into copula models for long-term survival projections: a case study in previously treated advanced esophageal squamous cell carcinoma
Poster session 4: Tuesday, May 7th from 3:30 pm – 6:30 pm
Influential Factors on the Economic Justifiable Price. Systematic Investigation of Factors and Mechanisms Beyond the Incremental Cost Effectiveness Ratio
Poster session 1: Monday, May 6th from 10:30 am – 1:30 pm
Long-term impact of new health policy and legislative initiatives
Moving Towards Inclusion – a Review of Access to Oncologic Therapies in the Light of Global Efforts to Advance Gender Equality
Poster session 3: Tuesday, May 7th from 10:30 am – 1:30 pm
The European Health Data Space (EHDS): Probable Impact, Possible Challenges and Proposed Solutions to Using Electronic Health Records (EHRS) for Research and Policy Shaping in the Region
Poster session 2: Monday, May 6th from 3:30 pm – 6:30 pm
Reimbursement of Medical Devices for Home Care: Worldwide Scenario, Challenges and Proposed Solutions
Poster session 2: Monday, May 6th from 3:30 pm – 6:30 pm
Communication of clinical, economic, and real-world evidentiary differentiators
Adherence of Treatment in Psoriasis- a Systematic Literature Review
Poster session 2: Monday, May 6th from 3:30 pm – 6:30 pm
Regulatory Vs HTA Divergences- Can the Real-World Evidence (RWE) be the Connecting Bridge?
Poster session 4: Tuesday, May 7th from 3:30 pm – 6:30 pm
Redefining the Scope: The Urgent Need for Holistic Multiple Sclerosis Modeling in Health Economics
Poster session 4: Tuesday, May 7th from 3:30 pm – 6:30 pm
Evolving trends in HTA assessments and/or collaborations across HTAs
What Are the Reasons for Receiving a Negative Decision from NICE? - a 5-Year Review (2019-2023) of NICE Decisions
Poster session 1: Monday, May 6th from 10:30 am – 1:30 pm
Navigating and leveraging AI for optimized patient access
Augmenting Health Economic Evidence Analysis: The Synergistic Role of AI in Deductive, Abductive Reasoning, and Insight Generation
Poster session 2: Monday, May 6th from 3:30 pm – 6:30 pm
Use of patient-centric approaches in clinical trials and drug development and evaluation of treatments
Using Survey Data and Qualitative Interviews to Support Content Validity for Spinocerebellar Ataxia (SCA) Patients
Poster session 3: Tuesday, May 7th from 10:30 am – 1:30 pm
Impact of Caring for Persons with Schizophrenia: Review of Burden Assessment Measures
Poster session 3: Tuesday, May 7th from 10:30 am – 1:30 pm
Saturation Reporting in COA Development and Validation Studies: A Scoping Overview
Poster session 5: Wednesday, May 8th from 9:00 am – 11:30 am
Exploring Simplified Screening Cut-Offs: Classification of KCNQ2-DEE Patients into Age-Adjusted Disease Phenotypes
Poster session 4: Tuesday, May 7th from 3:30 pm – 6:30 pm